AnaptysBio Inc risk profile
21 Normal where most of the sector sits
Measured 21 October 2026 from ANAB's filed statements. Recomputed nightly.
21 (Normal), driven by Market expectation at 63, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 63 | Stretched | Volatile | One-year price volatility — 87.4% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 23 | Normal | Easing | Free-cash-flow margin — 8.4% |
| Leverage and coverage | 32 | Normal | Stable | Interest cover — 0.61x |
| Competitive position | 8 | Contained | Stable | Operating-margin gap against peers — +16.7 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.